Financials

News Discussions Technicals Forecast Seasonals

688382 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

InventisBio, Co., Ltd. engages in drug research and development focusing on major diseases such as tumors and metabolic diseases. Its drugs have been developed to cover solid tumors such as non-small cell lung, breast, and colorectal cancer, as well as metabolic diseases such as hyperuricemia and gout. The company was founded by Yaolin Wang on January 11, 2013 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688382 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company